Tepha, Inc. is a medical device firm pursuing the development and commercialization of innovative products based on the Company’s proprietary biomaterial technology. The technology provides a new class of absorbable biomaterials, known as polyhydroxyalkanoates (a.k.a. PHAs), which may be tailored to meet unmet needs for medical devices in multiple fields.